El Vínculo El Vínculo.
Closed European Union SuppliesFramework agreement

Kasvajavastased ained, immunosupressandid, oftalmoloogias kasutatavad ained, hingamisteede obstruktiivsete haiguste raviks kasutatavad ained, migreenivastased ained

Buyer: sihtasutus Põhja-Eesti Regionaalhaigla

Open in El Vínculo
Published
8 November 2024
Submission deadline
11 December 2024, 10:00
Estimated value
€35,677,289
Procedure
Open procedure
Documents
1
Notice number
00681863-2024
Reference
05e2c35e-be4c-4f45-9942-7af296027829
Official source
Official source

CPV codes

Description

Kasvajavastaste ainete, immunosupressantide, oftalmoloogias kasutatavate ainete, hingamisteede obstruktiivsete haiguste raviks kasutatavate ainete, migreenivastaste ainete ostmine

Lots (32)

LotDescriptionCPV codeAmount
1 Panitumumab
EE001
 33600000 Productos farmacéuticos €53,040
2 Gemtuzumabosogamtsiin
EE001
 33600000 Productos farmacéuticos €27,035
3 Brentuksimabvedotiin
EE001
 33600000 Productos farmacéuticos €408,900
4 Pertuzumab
EE001
 33600000 Productos farmacéuticos €883,840
5 Trastuzumabemtansiin
EE001
 33600000 Productos farmacéuticos €2,418,000
6 Obinutuzumab
EE001
 33600000 Productos farmacéuticos €433,200
7 Nivolumab
EE001
 33600000 Productos farmacéuticos €3,812,800
8 Pembrolizumab
EE001
 33600000 Productos farmacéuticos €7,547,400
9 Blinatumomab
EE001
 33600000 Productos farmacéuticos €39,420
10 Daratumumab
EE001
 33600000 Productos farmacéuticos €8,366,400
11 Inotuzumabosogamitsiin
EE001
 33600000 Productos farmacéuticos €62,600
12 Durvalumab
EE001
 33600000 Productos farmacéuticos €1,115,100
13 Atezolisumab
EE001
 33600000 Productos farmacéuticos €2,871,000
14 Ipilimumab
EE001
 33600000 Productos farmacéuticos €1,294,650
15 Karfilsomiib
EE001
 33600000 Productos farmacéuticos €299,000
16 Iksasomiib
EE001
 33600000 Productos farmacéuticos €140,200
17 Pertuzumab + trastuzumab
EE001
 33600000 Productos farmacéuticos €1,893,000
18 Küüliku anti-T-lümfotsüütne immuunoglobuliin
EE001
 33600000 Productos farmacéuticos €17,500
19 Okrelizumab
EE001
 33600000 Productos farmacéuticos €228,120
20 Vedolizumab
EE001
 33600000 Productos farmacéuticos €366,000
21 Golimumab
EE001
 33600000 Productos farmacéuticos €368,550
22 Anakinra
EE001
 33600000 Productos farmacéuticos €30,400
23 Ustekinumab
EE001
 33600000 Productos farmacéuticos €202,000
24 Sarilumab
EE001
 33600000 Productos farmacéuticos €157,600
25 Belimumab
EE001
 33600000 Productos farmacéuticos €11,664
26 Polatuzumabvedotiin
EE001
 33600000 Productos farmacéuticos €1,085,000
27 Omalizumab
EE001
 33600000 Productos farmacéuticos €336,600
28 Mepolizumab
EE001
 33600000 Productos farmacéuticos €440,220
29 Benralizumab
EE001
 33600000 Productos farmacéuticos €386,750
30 Tesepelumab
EE001
 33600000 Productos farmacéuticos €194,000

Award criteria

Official publications

Other tenders from sihtasutus Põhja-Eesti Regionaalhaigla

Frequently asked questions

What is the deadline to bid for this tender?
The submission deadline is 11 December 2024, 10:00. Check the official source, as dates can be modified.
What is the estimated value of this tender?
The estimated value published by the buyer is €35,677,289.
Who is the buyer of this tender?
The contracting authority is sihtasutus Põhja-Eesti Regionaalhaigla (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.